Attovia Therapeutics, Inc. (ATTO)

22.93 -0.73 (-3.09%) USD  |  NASDAQ  |  Sep 09, 16:00
22.93 0.00 (0.00%) After-Hours: 16:18
More

Attovia Therapeutics Shareholders Equity (Quarterly) : 112.77M for June 30, 2026

Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for ATTO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 112.77M
Date Value
March 31, 2026 132.71M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. 1.354B
Agenus, Inc. -199.08M
Amgen, Inc. 11.69B
Anika Therapeutics, Inc. 137.28M
BioCryst Pharmaceuticals, Inc. -454.29M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly) 128.35M
Total Liabilities (Quarterly) 15.58M
Debt to Equity Ratio 0.0384
Current Ratio 9.386